CORMEDIX INC. - COMMON STOCK

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

04 ноя 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

30 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

24 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

23 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

08 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

19 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

13 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

09 сен 2024 10:52:30 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

14 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

07 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Outpatient Availability of DefenCath

03 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

06 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

10 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

09 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

19 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

15 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference

11 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

08 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire